A Phase 1, Double-Blind, Placebo-Controlled, Sponsor Open, Randomized, Multiple Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04447943 In Healthy Volunteers When Combined With Donepezil.
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2011
At a glance
- Drugs Donepezil; PF 4447943
- Indications Alzheimer's disease; Attention deficit and disruptive behaviour disorders; Dementia; Migraine; Vascular dementia
- Focus Adverse reactions; Pharmacokinetics
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
- 03 Aug 2010 Last checked against ClinicalTrials.gov record.
- 03 Aug 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.